Higher interest rates drive ‘improving’ 2024 outlook for life insurers, Fitch reports
Fitch Ratings has revised its sector outlook for North American life insurers to "improving" from "neutral" for 2024, according to its outlook report for the sector.
Fitch expects the Fed’s monetary tightening to cease and potentially pivot towards monetary easing. “North American life insurers will still benefit from the higher interest rate environment in 2024, which will facilitate top-line growth and enhance margins,” said Senior Director Jamie Tucker. “Their strong balance sheets should partially mitigate potential slowdowns in economic growth or macroeconomic volatility.”
Macro and secular shifts continue to make commercial real estate a pressure point. While CRE exposure is material, property and geographic diversification make life insurer losses largely manageable relative to capital. Insurers most vulnerable to heightened pressure and losses will be those holding larger office concentrations and higher volumes of near-term maturities.
Another area to watch closely for life insurers in 2024 will be continued alternative Investment manager (Alt-IM) tie-ups. Fitch expects further integration between Alt-IMs and insurers with relationships more immediately focused on minority stakes and/or investments in sidecars or offshore reinsurance platforms, though the effect thus far has been neutral.
More Alt-IM/life insurer partnerships will also lead to increased allocations in private credit. “Banks’ increased retreat from lending could lead to some life insurers investing in less liquid, less transparent and more esoteric investments, which in a credit market downturn will warrant added scrutiny,” said Tucker.
Reinvestment rates will continue to rise
Currently, reinvestment rates are materially exceeding roll-off yields, improving margins. Fitch
expects portfolio rates to continue to increase in 2024 as interest rates stabilize at higher levels. While Fitch expects the Federal Reserve’s monetary tightening to cease and potentially pivot toward monetary easing, life insurers will benefit from asset rotations, and interest rates will remain materially higher compared with recent history. The higher interest rate environment is beneficial for most major product lines and alleviates pressure on certain legacy long-tail liabilities. Sales of spread-based liabilities will also remain robust, particularly fixed-rate annuities.
Policyholder behavior manageable due to structural protections
Policyholder behavior remained predictable in 2023 relative to movements in interest rates,
including through the bank failures in March. Lapsation/surrender activity remains elevated
compared with recent years, which Fitch expects to persist in 2024 due to higher interest rates
resulting in a wider set of attractive investment opportunities available to policyholders. However, withdrawal activity is not expected to materially deviate from dynamic lapse rate assumptions, barring a material upward shock in rates. Unrealized losses are expected to remain material for the industry based on the level of interest rates. Fitch expects strong ALM practices to mitigate the probability of its rated universe becoming forced sellers, including through cash flow and duration matching of assets and liabilities.
Credit losses to remain low
The credit environment is expected to remain relatively benign in 2024. However, certain asset
classes, such as leveraged loans, will be pressured by the higher interest rate environment, though they continue to weather the macroeconomic conditions and global uncertainties. Fitch expects life insurers to continue to shift portfolios to private asset classes to capture the illiquidity premium, though the higher interest rate environment decreases the likelihood that life insurers will overreach for yield in ways that increase vulnerability to a large market shock.
Favorably, exposure to below-investment-grade bonds remains low compared with historical
averages, with the industry generally shifting towards private assets as opposed to high yield,
though there has been a modest uptick in the proportion of bonds rated ‘BBB’ over recent periods, which could be vulnerable to rating migration in a credit market downturn. Fitch recognizes that performance across the various alternative investment managers (AIM) tie-ups may vary given that this strategy has not weathered a material credit market downturn.



Remodel Health's National Health Benefits Analysis Reveals Employers Can Anticipate a 30% Reduction in Healthcare Costs with ICHRA
Three Weeks Left of Open Enrollment for 2024 Health Insurance
Advisor News
- Different generations are hopeful about their future, despite varied goals
- Geopolitical instability and risk raise fears of Black Swan scenarios
- Structured Note Investors Recover $1.28M FINRA Award Against Fidelity
- Market reports turn economic trends into a strategic edge for advisors
- SEC in ‘active and detailed’ settlement talks with accused scammer Tai Lopez
More Advisor NewsAnnuity News
- Life Insurance and Annuity Providers Score High Marks from Financial Pros, but Lag on User Friendliness, JD Power Finds
- An Application for the Trademark “TACTICAL WEIGHTING” Has Been Filed by Great-West Life & Annuity Insurance Company: Great-West Life & Annuity Insurance Company
- Annexus and Americo Announce Strategic Partnership with Launch of Americo Benchmark Flex Fixed Indexed Annuity Suite
- Rethinking whether annuities are too late for older retirees
- Advising clients wanting to retire early: how annuities can bridge the gap
More Annuity NewsHealth/Employee Benefits News
- New Antibiotics Study Results Reported from Tehran University of Medical Sciences [Antibiotic consumption and medication cost in diabetic patients: Insights from Iran health insurance organization (IHIO) claims data]: Drugs and Therapies – Antibiotics
- Study Data from Humana Healthcare Research Update Knowledge of Type 2 Diabetes [Trends in use of continuous glucose monitors among individuals with type 2 diabetes enrolled in Medicare Advantage (2021-2023)]: Nutritional and Metabolic Diseases and Conditions – Type 2 Diabetes
- Research Data from Harvard Medical School Update Understanding of Managed Care (The
<i>
Lancet
</i> Commission On a Citizen-centred Health System for India): Managed Care
- New Managed Care Study Findings Have Been Reported by Researchers at University of Pennsylvania Perelman School of Medicine (Buprenorphine prescribing is increasingly delivered by primary care nurse practitioners to Medicaid beneficiaries): Managed Care
- Researchers at University of Maryland School of Public Health Have Reported New Data on Managed Care (Associations Between ACO Enrollment Status and Drug and Nondrug Costs Among Older Adults Newly Diagnosed With ADRD): Managed Care
More Health/Employee Benefits NewsProperty and Casualty News
- South Carolina House advances earthquake insurance bill. Here's what it includes
- State insurance commissioner wants insurance discounts for fortified roofs
- What do people use pet insurance for? In 2025, it wasn’t only emergency visits
- AM Best Affirms Credit Ratings of Cincinnati Financial Corporation and Subsidiaries
- OneShield Expands AI Hub Platform with Specialty Insurance Provider, Reinforcing AI-Native Strategy for the Insurance Industry
More Property and Casualty News